Evaluate provides trusted commercial intelligence to industry-leading companies of all sizes, including over 80% of the 100 pharma companies. We help our clients to refine and transform their understanding of the global pharmaceutical market to drive better decisions.
Our EvaluatePharma® and EvaluatePharma Vision online subscription services provide a seamless view of the past, present and future of the global pharmaceutical market in a single, standardised platform, including consensus forecasts to 2024, company financials, pipelines, deals, proprietary R&D performance analytics, and more.
Vantage – our award winning, independent editorial team – provides thought-provoking insights into the current and future developments in the industry.
Evaluate has been a partner to industry-leading organizations for over 20 years. For more information on how we give our clients the time and understanding to drive better decisions, visit us at www.evaluate.com.
On Twitter: @EvaluatePharma, @EvaluateMedtech, @Vantageanalysis.